Analysis of HIF-1α and its regulator, PHD2, in retroperitoneal sarcomas Clinico-pathologic implications.

MLA

Jui-Han Huang, et al. “Analysis of HIF-1α and Its Regulator, PHD2, in Retroperitoneal Sarcomas Clinico-Pathologic Implications.” Cancer Biology & Therapy, vol. 9, no. 4, Feb. 2010, pp. 303–11. EBSCOhost, https://doi.org/10.4161/cbt.9.4.10744.

APA

Jui-Han Huang, Lee, F. S., Pasha, T. L., Sammel, M. D., Karakousis, G., Xu, G., Fraker, D., & Zhang, P. J. (2010). Analysis of HIF-1α and its regulator, PHD2, in retroperitoneal sarcomas Clinico-pathologic implications. Cancer Biology & Therapy, 9(4), 303–311. https://doi.org/10.4161/cbt.9.4.10744

Chicago

Jui-Han Huang, Frank S. Lee, Theresa L. Pasha, Mary D. Sammel, Giorgos Karakousis, George Xu, Douglas Fraker, and Paul J. Zhang. 2010. “Analysis of HIF-1α and Its Regulator, PHD2, in Retroperitoneal Sarcomas Clinico-Pathologic Implications.” Cancer Biology & Therapy 9 (4): 303–11. doi:10.4161/cbt.9.4.10744.